 TEL AVIV, Israel, Jan. 19, 2021 PRNewswire -- BioLineRx Ltd. NASDAQ: BLRX TASE: BLRX, a late clinical-stage biopharmaceutical company focused on oncology, today announced that it has entered into an underwriting agreement with H.C. Wainwright Co., LLC under which the underwriter... 